Rank | Bedrijf | |
---|---|---|
1 | MSD | |
2 | SABIC | |
3 | Bayer | |
4 | BASF | |
5 | Abbott | |
6 | Janssen Biologics | |
7 | AkzoNobel | |
8 | Dow Benelux | |
9 | GlaxoSmithKline (GSK) | |
10 | Novartis | |
Strategie | Score | |
1 | MSD | |
2 | SABIC | |
3 | Bayer | |
4 | BASF | |
5 | Janssen Biologics | |
6 | Abbott | |
7 | AkzoNobel | |
8 | Dow Benelux | |
9 | GlaxoSmithKline (GSK) | |
10 | Novartis | |
Klant | Score | |
1 | SABIC | |
2 | Bayer | |
3 | MSD | |
4 | BASF | |
5 | Abbott | |
6 | AkzoNobel | |
7 | Janssen Biologics | |
8 | Novartis | |
9 | GlaxoSmithKline (GSK) | |
10 | Dow Benelux | |
Technologie | Score | |
1 | MSD | |
2 | Bayer | |
3 | Abbott | |
4 | SABIC | |
5 | Janssen Biologics | |
6 | BASF | |
7 | AkzoNobel | |
8 | GlaxoSmithKline (GSK) | |
9 | Dow Benelux | |
10 | Novartis | |
Organisatie | Score | |
1 | SABIC | |
2 | Bayer | |
3 | BASF | |
4 | Janssen Biologics | |
5 | Abbott | |
6 | AkzoNobel | |
7 | MSD | |
8 | Dow Benelux | |
9 | Novartis | |
10 | GlaxoSmithKline (GSK) |